Dyne Therapeutics leverages its FORCE platform to target genetically driven muscle diseases with two lead clinical programs approaching pivotal milestones. DYNE-101 shows strong safety and functional ...

Mission autonomy software by Collins and Shield AI was integrated on the YFQ-42 and YFQ-44 CCAs by using the government-owned A-GRA architecture. The U.S. Air Force has reached a new milestone in its ...